Novanta (NOVT) Current Deferred Revenue (2017 - 2025)
Historic Current Deferred Revenue for Novanta (NOVT) over the last 13 years, with Q3 2025 value amounting to $8.0 million.
- Novanta's Current Deferred Revenue fell 374.01% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 374.01%. This contributed to the annual value of $5.7 million for FY2024, which is 291.73% up from last year.
- According to the latest figures from Q3 2025, Novanta's Current Deferred Revenue is $8.0 million, which was down 374.01% from $6.9 million recorded in Q2 2025.
- In the past 5 years, Novanta's Current Deferred Revenue ranged from a high of $9.2 million in Q4 2021 and a low of $5.3 million during Q2 2021
- Its 5-year average for Current Deferred Revenue is $7.0 million, with a median of $6.9 million in 2023.
- Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 10242.29% in 2021, then crashed by 3168.06% in 2023.
- Over the past 5 years, Novanta's Current Deferred Revenue (Quarter) stood at $7.0 million in 2021, then rose by 16.2% to $8.1 million in 2022, then crashed by 31.68% to $5.6 million in 2023, then rose by 2.92% to $5.7 million in 2024, then skyrocketed by 40.51% to $8.0 million in 2025.
- Its Current Deferred Revenue was $8.0 million in Q3 2025, compared to $6.9 million in Q2 2025 and $8.2 million in Q1 2025.